Technical Analysis for CRBP - Corbus Pharmaceuticals Holdings, Inc.
|Grade||Last Price||% Change||Price Change|
CRBP closed up 2.07 percent on Tuesday, December 11, 2018, on 30 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
|Weak or Absent||Up||Up||Up|
|See historical CRBP trend table...|
|Date||Alert Name||Type||% Chg|
|Dec 11||Crossed Above 50 DMA||Bullish||0.00%|
|Dec 11||NR7||Range Contraction||0.00%|
|Dec 11||Inside Day||Range Contraction||0.00%|
|Dec 10||Fell Below 50 DMA||Bearish||2.07%|
|Dec 10||20 DMA Support||Bullish||2.07%|
|Dec 7||Crossed Above 50 DMA||Bullish||0.00%|
|Dec 7||MACD Bullish Centerline Cross||Bullish||0.00%|
|Dec 7||Pocket Pivot||Bullish Swing Setup||0.00%|
|Dec 7||Upper Bollinger Band Touch||Strength||0.00%|
|Dec 6||20 DMA Support||Bullish||3.60%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Corbus Pharmaceuticals Holdings, Inc., a clinical stage biopharmaceutical company, develops and commercializes novel therapeutics to treat inflammatory-fibrotic diseases. The company primarily develops Resunab, an oral anti-inflammatory drug that has completed Phase I clinical trials for the treatment of cystic fibrosis and diffuse scleroderma. It sells its products through hearing professionals, including audiologists, hearing aid specialists, and ENT doctors worldwide. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CRBP news...
|52 Week High||9.955|
|52 Week Low||4.5|
|200-Day Moving Average||6.125|
|50-Day Moving Average||6.8272|
|20-Day Moving Average||6.461|
|10-Day Moving Average||6.744|
|Average True Range||0.4443|
|Chandelier Exit (Long, 3 ATRs )||6.3271|
|Chandelier Exit (Short, 3 ATRs )||7.0029|
|Upper Bollinger Band||7.1262|
|Lower Bollinger Band||5.7958|
|Percent B (%b)||0.83|
|MACD Signal Line||-0.0176|
|Market Cap||346.52 Million|
|Num Shares||50.2 Million|
|Price-to-Earnings (P/E) Ratio||-11.50|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||7.32|
|Resistance 3 (R3)||7.28||7.10||7.25|
|Resistance 2 (R2)||7.10||6.99||7.12||7.23|
|Resistance 1 (R1)||7.00||6.93||7.05||7.04||7.20|
|Support 1 (S1)||6.72||6.71||6.77||6.76||6.60|
|Support 2 (S2)||6.54||6.65||6.56||6.57|
|Support 3 (S3)||6.44||6.54||6.55|
|Support 4 (S4)||6.48|